The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

The secondary cascade, although a normal physiological response, can contribute to ongoing neuroinflammation, oxidative ...

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

In the U.S., key risk factors for Alzheimer's disease were tied to cognitive ... The agency also expanded the indication for diazepam nasal spray (Valtoco) for short-term treatment of seizure ...